The 1945-1949 droughts in Switzerland

This paper studies the representation of a drought period that affected Central Europe from 1945 to 1949 in the “Twentieth Century Reanalysis” (20CR). We analysed temperature and precipitation fields in 20CR and compared them to other data products. From the monthly precipitation rate at a 20CR grid point in the Swiss Plateau, the Standardised Precipitation Index over six months (SPI6) was calculated and compared with the corresponding index calculated from station data. For additional analyses, 20CR soil moisture, run off, and evaporation data were used. 20CR well reproduces the temperature and precipitation anomalies over Central Europe during this period, although during 1947, the precipitation anomaly is shifted to the east as compared to observations. With respect to the SPI6 index, the agreement between 20CR and station data is good except again for 1947 (conversely, drought was overestimated in 20CR for 1945 and 1949). Low SPI values in 20CR are accompanied by negative soil moisture anomalies and a negative water balance. Thus, apart from the shift in the spatial drought pattern in 1947, the drought is depicted in a realistic way in 20CR.

Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy.

Neoadjuvant platin-based therapy is accepted as a standard therapy for advanced esophageal adenocarcinoma (EAC). Patients who respond have a better survival prognosis, but still a significant number of responder patients die from tumor recurrence. Molecular markers for prognosis in neoadjuvantly treated EAC patients have not been identified yet. We investigated the epidermal growth factor receptor (EGFR) in prognosis and chemotherapy resistance in these patients. Two EAC patient cohorts, either treated by neoadjuvant cisplatin-based chemotherapy followed by surgery (n=86) or by surgical resection (n=46) were analyzed for EGFR protein expression and gene copy number. Data were correlated with clinical and histopathological response, disease-free and overall survival. In case of EGFR overexpression, the prognosis for neoadjuvant chemotherapy responders was poor as in non-responders. Responders had a significantly better disease-free survival than non-responders only if EGFR expression level (p=0.0152) or copy number (p=0.0050) was low. Comparing neoadjuvantly treated patients and primary resection patients, tumors of non-responder patients more frequently exhibited EGFR overexpression, providing evidence that EGFR is a factor for indicating chemotherapy resistance. EGFR overexpression and gene copy number are independent adverse prognostic factors for neoadjuvant chemotherapy-treated EAC patients, particularly for responders. Furthermore, EGFR overexpression is involved in resistance to cisplatin-based neoadjuvant chemotherapy.